Steven S. Myers - 08 Dec 2021 Form 4 Insider Report for CALADRIUS BIOSCIENCES, INC. (LSTA)

Role: Director
Signature: Steven S. Myers, By: /s/ Todd C. Girolamo, Esq., Attorney-in-Fact
Issuer symbol: LSTA
Transactions as of: 08 Dec 2021
Net transactions value: +$30,190
Form type: 4
Filing time: 10 Dec 2021, 16:03:59 UTC
Next filing: 12 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LSTA	Common Stock	Purchase	$30,190	+33,785	+30%	$0.8936	146,839	08 Dec 2021	Direct	F1, F2
holding	LSTA	Common Stock						8,434	08 Dec 2021	By Steven S Myers IRA
holding	LSTA	Common Stock						1,954	08 Dec 2021	By Steven S Myers Revocable Trust dated 12/1/2000
holding	LSTA	Common Stock						802	08 Dec 2021	By spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8802 to $0.9000, inclusive. The reporting person undertakes to provide Caladrius Biosciences, Inc., any security holder of Caladrius Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F2	Represents 37,735 unvested restricted stock awards granted under Issuer's 2018 Equity Incentive Compensation plan, which will vest on January 11, 2022.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8802 to $0.9000, inclusive. The reporting person undertakes to provide Caladrius Biosciences, Inc., any security holder of Caladrius Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Represents 37,735 unvested restricted stock awards granted under Issuer's 2018 Equity Incentive Compensation plan, which will vest on January 11, 2022.